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Type 1 diabetes mellitusAbstract Diabetic nephropathy (DNP) is a microvascular complication that occurs in 20–40% of
patients with type 1 diabetes (T1D). The main modiﬁable DNP initiation and progression factors in
susceptible individuals may be sustained hyperglycemia and hypertension. The aim of the present
work was to study glycemic control in children with T1D and the risk of microalbuminuria
(MA) expressed as the urinary albumin/creatinine ratio (ACR).
Subjects and methods: Forty children with T1D attending the diabetes clinic at the Alexandria
University Children’s Hospital with a duration of diabetes of 3 years or more were included in
the study and twenty apparently normal children were taken as controls. Clinical examination
and blood pressure measurements were performed for all cases. Urine samples were collected within
a 3–6 month period. The ACR in 2 of 3 specimens should be >30 mg/g before considering a patient
to have microalbuminuria. HbA1c was measured and the mean of the last 4 readings was calcu-
lated.
Results: 77.5% of patients had ACR >30 mg/g in two different samples. 88.8% of patients with
poor glycemic control had MA compared to 53.8% with accepted glycemic control. The difference
was more statistically signiﬁcant among the adolescent age group (P= 0.001). MA was found in
77.2% of children with duration of T1D less than 5 years but the highest proportion was found
when the disease duration was more than 10 years. There was no signiﬁcant difference in systolic
and diastolic blood pressure among diabetic children with and without MA (P= 0.556 and 0.781).
84 M.A. Omar et al.Conclusion: Microalbuminuria in children with T1 DM is not limited to those with disease
duration of 5 years or more and it may occur earlier. MA is signiﬁcantly associated with poor gly-
cemic control especially in adolescents. Other factors that may contribute to MA are not yet fully
understood, further research is needed to clarify these factors.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
The chronic hyperglycemia of diabetes is mostly associated
with long-term damage, dysfunction, and failure of different
organs, especially the eyes, kidneys, nerves, heart, and blood
vessels.1
Diabetic microvascular and macrovascular complications
may have similar etiologic characteristics. Chronic hyper-
glycemia plays a major role in the initiation of diabetic
vascular complications through many metabolic and struc-
tural derangements, including the production of advanced
glycation end products (AGE), abnormal activation of sig-
naling cascades such as protein kinase C, elevated produc-
tion of reactive oxygen species (ROS, oxygen-containing
molecules that can interact with other biomolecules and
result in damage), and abnormal stimulation of hemody-
namic regulation systems, such as the renin-angiotensin
system [RAS].2
Diabetic nephropathy (DNP) is a microvascular
complication that occurs in 20–40% of patients with
diabetes and is the single leading cause of end-stage renal
disease (ESRD). The main potentially modiﬁable DNP
initiation and progression factors in susceptible individuals
may be sustained hyperglycemia and hypertension.3
The earliest clinical evidence of nephropathy is the
appearance of low but abnormal levels of albumin in the urine
(>30 mg/day or 20 lg/min), referred to as microalbuminuria
(MA), and patients with MA are referred to as having incipient
nephropathy. Without speciﬁc interventions, 80% of subjects
with type 1 diabetes who develop sustained MA have their uri-
nary albumin excretion increase at a rate of 10–20% per year
to the stage of overt nephropathy or clinical albuminuria
(300 mg/24 h or 200 lg/min) over a period of 10–15 years, with
hypertension also developing along the way. Once overt
nephropathy occurs, without speciﬁc interventions, the glomer-
ular ﬁltration rate (GFR) gradually falls over a period of several
years at a rate that is highly variable from individual to individ-
ual (2–20 ml min1 year1). Eventually, ESRDdevelops in 50%
of type 1 diabetic individuals with overt nephropathy within
10 years and in >75% by 20 years.3
The Diabetes Control and Complication Trial (DCCT), a
prospective, randomized, controlled trial of intensive versus
standard glycemic control in patients with T1D showed that
improved glycemic control is associated with signiﬁcantly
decreased rates of microvascular complications (retinopathy,
nephropathy and neuropathy).4
However, fewer data exist on the relation between HbA1c
and risk of MA in children with type 1 DM.5
The aim of the present work was to study glycemic control
in T1D expressed as the mean of the last 4 readings of glycated
hemoglobin (HbA1c) and the risk of MA expressed as the uri-
nary albumin/creatinine ratio (ACR).2. Subjects and methods
This study was conducted on 40 patients diagnosed with T1D
attending the diabetes clinic at the Alexandria University Chil-
dren’s Hospital. The inclusion criteria were: type 1 DM, age:
5–18 years and duration of DM 3 years or more. Patients with
evident organ system disease like hemolytic anemia and
patients receiving drugs known to affect urinary albumin
excretion e.g. corticosteroids, were excluded.
Ethical approval was obtained from the Ethics Committee
of the Alexandria Faculty of Medicine and an informed con-
sent was obtained from parents.
All cases were subjected to complete history taking and
clinical examination. Arterial blood pressure was measured
on the right arm with a standard clinical sphygmomanometer
after the patient had been sitting for 10 min. Cases with blood
pressure values P90th centile for age were considered
prehypertensive while cases P95th centile were considered
hypertensive.6
Quantitative determination of microalbumin (lALB) was
done by urinary microalbumin–turbilatex which is a quantita-
tive turbidimetric test for measurement of lALB in human
urine. Urinary creatinine was measured using an automated
colorimetric determination based on a modiﬁed Jaffe reac-
tion.7 The albumin/creatinine ratio was obtained by dividing
microalbumin (mg/L) by creatinine (g/L). Because of variabil-
ity in urinary albumin excretion (UAE), two of three speci-
mens collected within a 3–6 month period should be
abnormal before considering a patient to have abnormal albu-
min/creatinine ratio.8
HbA1c was measured by Nyco Card and the mean of the
last 4 readings was calculated. The age was considered when
setting glycemic goals in children and adolescents with type 1
diabetes i.e. for toddlers, 8.5% was considered accepted,
school age <8% and in adolescents <7.5%.9
Data were fed to the computer using SPSS software pack-
age version 20. Qualitative data were described using number
and percent. Comparison between different groups regarding
categorical variables was tested using Chi-square test. Quanti-
tative data were described using mean and standard deviation.
Signiﬁcance was determined as P< 0.05.
3. Results
Table 1 shows that both cases and controls were comparable as
regards age and sex but showed a signiﬁcant difference in fam-
ily history of DM (P=<0.001). The mean duration of DM in
the cases was 6.77 ± 3.1 years. It shows also that in 31 out of
40 cases (77.5%) ACR was >30 mg/g in two different samples
collected within a 3–6 month period. None of the controls had
ACR >30 mg/g.
Table 2 shows the age anddurationofT1DMinpatientswith
accepted glucose control versus poor control. The statistical
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Figure 1 Control of T1 DM and microalbuminuria.
Table 1 Patients with T1 DM and controls according to some socio-demographic characteristics and the prevalence of
Microalbuminuria.
Patients with T1 DM Controls P
No % No %
Age
Min.–Max. 5.0–18.0 5.0–18.0 tP= 0.083
Mean ± SD 11.78 ± 3.83 10.0 ± 3.34
Median 11.75 9.5
Sex
Male 12 30 7 35 0.695
Female 28 70 13 65
Duration of diabetes
Min.–Max. 3.0–15 – –
Mean ± SD 6.77 ± 3.1 – –
Family history of diabetes
Yes 17 42.5 0 0 FE P< 0.001*
No 23 57.5 20 100
Microalbuminuria
Present 31 77.5 0 0 FE P< 0.001*
Absent 9 22.5 20 100
P: P value for Chi-square test.
* FEP: P value for Fisher Exact test.
t P: P value for Student’s t-test.
Table 2 The age and duration of T1 DM in patients with accepted glucose control versus poor control.
Patients with accepted control Patients with poor control Total P
No % No % No %
Patients’ age
Toddler < 6 years 1 100 0 0 1 100 0.252
School age 6–12 7 37 12 63 19 100
Adolescent 13–19 5 25 15 75 20 100
Duration of diabetes in years
3 to <5 5 55.6 4 44.4 9 100 0.245
5–10 6 26 17 74 23 100
>10 2 25 6 75 8 100
Microalbuminuria and glycated hemoglobin in children with T1D 85comparison among different groups revealed no statistically sig-
niﬁcant difference.
Fig. 1 shows that poor glycemic control was associated with
higher proportion of MA. Twenty-four out of the 27 cases
(88.8%) with poor glycemic control had MA, compared to 7
out of the 13 cases (53.8%) with good glycemic control. The
difference was statistically signiﬁcant (P= 0.013).
Table 3 shows that 15 out of the 19 school age diabetic chil-
dren had MA (78.9%), whereas, in adolescents, 16 out of 20
had MA (80%). However, the difference was not statistically
signiﬁcant (P= 0.170).
There was no signiﬁcant sex predominance as 78.5% of
females were found to have MA compared to 75% of males
(P= 0.804).
Table 3 shows that MA was found in 77.2% of children
with a duration of diabetes mellitus less than 5 years but the
highest proportion was found when the disease duration was
more than 10 years (7 out of 8 cases; 87.5%). However, the dif-
ferences among the groups were not statistically signiﬁcant.
Table 3 Factors that may affect the occurrence of MA in patients with T1 DM.
Total Microalbuminuria (31) Normoalbuminuria (9) P
No % No % No %
Age (years)
Toddler < 6 1 100 0 0 1 100
School age 6–12 19 100 15 78.9 4 21.1 0.170
Adolescent 13–19 20 100 16 80 4 20
Sex
Male 12 100 9 75 3 25 0.804
Female 28 100 22 78.5 6 21.6
Duration of DM
3 to <5 years 9 100 7 77.7 2 22.2
5 to 10 years 23 100 17 73.9 6 26 0.730
>10 years 8 100 7 87.5 1 12.5
Control of DM
Toddler < 6 years
Good control (HbA1c%< 8.5) 1 100 0 0 1 100
Poor control (HbA1c%> 8.5) 0 0 0 0 0 0
School age 6–12
Good control (HbA1c%< 8) 7 100 6 85.7 1 14.3 0.891
Poor control (HbA1c%> 8) 12 100 10 83.3 2 16.6
Adolescent 13–19
Good control (HbA1c%< 7.5) 5 100 1 20 4 80 0.001*
Poor control (HbA1c%> 7.5) 15 100 14 93.3 1 6.6
Systolic blood pressure
<90th percentile 37 100 29 78.4 8 21.6
90–95th percentile 1 100 1 100 0 0 0.556
>95th percentile 2 100 1 50 1 50
Diastolic blood pressure
<90th percentile 25 100 20 80 5 20
90–95th percentile 6 100 4 66.7 2 33.3 0.781
>95th percentile 9 100 7 77.8 2 22.2
* Statistically signiﬁcant at P 6 0.05.
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associated with higher proportion of MA. Fourteen out of the
15 cases with poor glycemic control (93.3%) while only 1 out
of the 5 (20%) among those with accepted glycemic control
had MA. The difference was only signiﬁcant among the ado-
lescent group (13–19 years) P= 0.001. There was no signiﬁ-
cant difference in systolic and diastolic blood pressure
among diabetic children with and without MA (P= 0.556
and 0.781, respectively).4. Discussion
Diabetes mellitus is the most common endocrine metabolic dis-
order in childhood and adolescence. During the last decade,
pediatricians have become increasingly interested in long term
complications of diabetes; this is because of the recent scientiﬁc
developments that allow the detection of minor abnormalities
in asymptomatic diabetic patients, and allow early preventive
interventions.10
MA is considered to be an early sign of diabetic renal dis-
ease. It precedes persistent proteinuria and represents a poten-
tially reversible stage of diabetic nephropathy.11,12 The risk of
DNP is highest in those who develop type 1 diabetes in
childhood.13 It has been linked to increased levels of advanced
glycation end products, disturbed lipid metabolism andabnormalities in hemostasis evidenced by the hypercoagulabil-
ity due to increased coagulation factors and/or diminished
ﬁbrinolytic activity.14,15
The prevalence of early nephropathy as evidenced by ele-
vated ACR, among children and adolescents with type 1 diabe-
tes varies much between different studies. The present study
showed that 31 out of 40 diabetic children (77.5%) had early
nephropathy which is higher than the average reported by
the ADA (20–40%).8 In a Danish study the prevalence was
13%.16 In the United Kingdom, Gizmecioglu et al.17 showed
that elevated ACR occurred in 9%, however, less developed
countries reported higher ﬁgures. In a study in Iraq, MA
occurred in 41.4% of patients which is higher than those of
the previous two studies but still lower than ﬁgures in the pres-
ent study.18 In an Iranian study MA occurred in 34.6% of 81
diabetic children and adolescents.19 As the previous ﬁgures
show, the variation is wide and may be related mainly to the
degree of diabetes control as it is affected by education, socio-
economic status and the inﬂuence of race/ethnicity. Improper
collection and storage of urine samples may affect measured
levels of MA, as urine proteins are signiﬁcantly but variably
underestimated after storage at 20 C.20 DNP due to T1D
remains a disease involving a heavy burden of morbi-mortality
and is difﬁcult to manage in a developing country because of
the low socioeconomic level of patients and the lack of reliable
epidemiological data.21
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expressed as the mean of the last 4 readings of HbA1c, with
sex, patient’s age, and the duration of DM was examined.
More than two thirds of patients (67.5%) had poor glycemic
control according to age-adjusted HbA1c targets. This was
higher than previously reported from Egypt. Mohamed et al,
reported that children with poor glycemic control occurred
in 45.8%, but it was still lower than that reported in other
developing countries like Iran, where abnormal HbA1c
occurred in 82.7% of patients.3,19
The degree of glycemic control among the different age
groups revealed no statistically signiﬁcant difference;Mohamed
et al., reported that children with poor glycemic control had sig-
niﬁcantly higher mean age.13 Similarly, Vanelli et al.22 reported
that increasing age was associated with a higher mean HbA1c
and a decreased likelihood of attaining HbA1c in the target
range regardless of the insulin regimen. It has been argued that
poor glycemic control in adolescents is directly proportional to
increasing age. This may be related to physiologic insulin resis-
tance because of increased sex steroids, growth hormone and
diminished free Insulin-like growth factor 1 (IGF1). Further-
more, pubertal development and the transition to adulthood
are associated with problems in adapting to lifestyle that
requires selfmanagement of dietary practices, exercise behavior,
insulin adjustment and adherence to treatment management.8
The present results showed that poor glycemic control was asso-
ciated with higher proportion of nephropathy as 88.8% of cases
with poor glycemic control had increased ACR, compared to
53.8% with good glycemic control (P= 0.013). This was more
evident in the adolescent age group as 93.3%with poor glycemic
control had abnormal albumin/creatinine ratio compared to
20% with good glycemic control (P= 0.001). These results
show a signiﬁcant relationship between the degree of glycemic
control and the occurrence of nephropathy and are in agreement
with the epidemiological analysis of the DCCT and the United
Kingdom Prospective Diabetes Study (UKPDS) where a curvi-
linear relationship between HbA1c and microvascular compli-
cation was demonstrated.4
In an Iranian study it was shown that poor glycemic control
was observed in 82.7%; however, there was no correlation
between MA and HbA1c.19 Chae et al. showed that the mean
HbA1c levels were signiﬁcantly higher in the MA group than
in the normoalbuminuria group suggesting that the incidence
of DNP increases according to the degree of glycemic
control.23
The present work showed that the highest proportion of
cases with nephropathy was found if the duration of diabetes
was more than 10 years (7 out of 8 cases, 87.5%). However,
the differences among the groups were not statistically signiﬁ-
cant. Chae et al.23 observed that the duration of diabetes was
signiﬁcantly higher in the microalbuminuria group while Bas-
iratnia et al.19observed there was no signiﬁcant correlation
between the duration and microalbuminuria. This insigniﬁcant
correlation between MA and the duration of DM may be
explained by the fact that the mean duration of DM in this
study was 6.77 ± 3.1 years, which may be considered a short
time to develop nephropathy. Surprisingly, MA was found in
77.2% of children with a duration of diabetes mellitus less than
5 years. It was concluded by Alleyn et al.24 that microalbumin-
uria in older children with type 1 diabetes is likely to be clini-
cally signiﬁcant. In younger children, it may reﬂect functional,
reversible renal changes.Hypertension is another modiﬁable risk factor that accel-
erates the progression of micro- and macrovascular compli-
cations.8 Gross and coworkers suggested that the
development and progression of MA is closely linked to
hypertension.25 Other studies suggest that impairment of
blood pressure regulation begins at nighttime with a higher
prevalence than microalbuminuria. However, ofﬁce blood
pressure measurement did not rise before the onset of micro-
albuminuria.26 In the present study, systolic and diastolic
blood pressure did not signiﬁcantly differ among cases with
and without MA. Various studies have revealed conﬂicting
results; some of these studies did not show any signiﬁcant
role of blood pressure on MA,22 while others have revealed
that high blood pressure, especially diastolic pressure, is one
of the important predictors of developing MA. It is possible
that blood pressure only increases in relation to the onset of
microalbuminuria, either shortly before or after, and thus
only is a short term risk factor. Another possibility is that
the changes in blood pressure initially are so small that they
are not detectable with baseline ofﬁce measurements and
that 24-h ambulatory blood pressure measurement is
necessary to demonstrate their presence.27,28 However, the
relationship between MA and blood pressure is still contro-
versial. It may be claimed that blood pressure is not an
important initiating factor for MA in children with type 1
diabetes.29,30 Conﬂicting results may be related also to the
different methods used in measuring blood pressure espe-
cially in children.
In conclusion, microalbuminuria in children with T1 DM is
not limited to those with disease duration 5 years or more and
it may occur earlier. MA is signiﬁcantly associated with poor
glycemic control especially in adolescents. Other factors that
may contribute to MA are not yet fully understood, further
research is needed to clarify these factors.Conﬂict of interest
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